Literature DB >> 19243303

Isoform-specific ras functions in development and cancer.

Margaret P Quinlan1, Jeffrey Settleman.   

Abstract

The three closely related mammalian ras genes, Hras, Nras and Kras, have each been implicated in human tumorigenesis by virtue of mutational activation. However, while these genes encode proteins with very similar biochemical properties, activating ras alleles corresponding to the various isoforms have been linked to particular malignancies. Accumulating evidence suggests that these proteins exert distinct activities in a tissue-specific context, apparently reflecting developmental lineage-specific roles for the various ras isoforms. Some of these distinct functions appear to reflect differences in their C-termini, which determine distinct subcellular localization, thereby suggesting a role for compartmentalized signaling. In this review, we discuss the biological functions of the ras isoforms in the context of tissue-specific function as it relates to ras function in development and human cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19243303     DOI: 10.2217/14796694.5.1.105

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  47 in total

Review 1.  Delving into somatic variation in sporadic melanoma.

Authors:  Vijay Walia; Euphemia W Mu; Jimmy C Lin; Yardena Samuels
Journal:  Pigment Cell Melanoma Res       Date:  2012-02-13       Impact factor: 4.693

Review 2.  Using CellMiner 1.6 for Systems Pharmacology and Genomic Analysis of the NCI-60.

Authors:  William C Reinhold; Margot Sunshine; Sudhir Varma; James H Doroshow; Yves Pommier
Journal:  Clin Cancer Res       Date:  2015-06-05       Impact factor: 12.531

3.  Increased wild-type N-ras activation by neurofibromin down-regulation increases human neuroblastoma stem cell malignancy.

Authors:  Dan Han; Barbara A Spengler; Robert A Ross
Journal:  Genes Cancer       Date:  2011-11

4.  Raf-1 Cysteine-Rich Domain Increases the Affinity of K-Ras/Raf at the Membrane, Promoting MAPK Signaling.

Authors:  Shuai Li; Hyunbum Jang; Jian Zhang; Ruth Nussinov
Journal:  Structure       Date:  2018-02-08       Impact factor: 5.006

5.  Selective targeting of point-mutated KRAS through artificial microRNAs.

Authors:  Mario Acunzo; Giulia Romano; Giovanni Nigita; Dario Veneziano; Luigi Fattore; Alessandro Laganà; Nicola Zanesi; Paolo Fadda; Matteo Fassan; Lara Rizzotto; Raleigh Kladney; Vincenzo Coppola; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-08       Impact factor: 11.205

6.  Structural basis of recognition of farnesylated and methylated KRAS4b by PDEδ.

Authors:  Srisathiyanarayanan Dharmaiah; Lakshman Bindu; Timothy H Tran; William K Gillette; Peter H Frank; Rodolfo Ghirlando; Dwight V Nissley; Dominic Esposito; Frank McCormick; Andrew G Stephen; Dhirendra K Simanshu
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-17       Impact factor: 11.205

7.  NRAS mutations are rare in colorectal cancer.

Authors:  Natsumi Irahara; Yoshifumi Baba; Katsuhiko Nosho; Kaori Shima; Liying Yan; Dora Dias-Santagata; Anthony John Iafrate; Charles S Fuchs; Kevin M Haigis; Shuji Ogino
Journal:  Diagn Mol Pathol       Date:  2010-09

8.  Resequencing analysis of the candidate tyrosine kinase and RAS pathway gene families in multiple myeloma.

Authors:  Vishwanathan Hucthagowder; Rekha Meyer; Chelsea Mullins; Rakesh Nagarajan; John F DiPersio; Ravi Vij; Michael H Tomasson; Shashikant Kulkarni
Journal:  Cancer Genet       Date:  2012-09

Review 9.  Lessons learned from next-generation sequencing in head and neck cancer.

Authors:  Myriam Loyo; Ryan J Li; Chetan Bettegowda; Curtis R Pickering; Mitchell J Frederick; Jeffrey N Myers; Nishant Agrawal
Journal:  Head Neck       Date:  2012-08-21       Impact factor: 3.147

10.  Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas.

Authors:  Nicolas Girard; Ronglai Shen; Tianhua Guo; Maureen F Zakowski; Adriana Heguy; Gregory J Riely; James Huang; Christopher Lau; Alex E Lash; Marc Ladanyi; Agnes Viale; Cristina R Antonescu; William D Travis; Valerie W Rusch; Mark G Kris; William Pao
Journal:  Clin Cancer Res       Date:  2009-10-27       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.